CHRM1 and Alzheimer disease: Thus, Niwa et al. (2018) have reported that CRISPR/Cas9-mediated knockout of the Chrm1 gene encoding M1 mAChR reduces REM sleep, which is a known AD feature (Liguori et al., 2016).